<?xml version="1.0" ?>
<document id="30272645">
  <sentence id="30272645.s0" text="Familial hypercholesterolemia (FH) is mostly caused by low-density lipoprotein receptor (intestinal cholesterol absorption) mutations and results in an increased risk of early-onset cardiovascular disease due to marked elevation of LDL cholesterol (LDL-C) in blood.">
    <entity charOffset="9-29" id="30272645.s0.e0" ontology_id="HP_0003124" text="hypercholesterolemia" type="HP"/>
    <entity charOffset="89-122" id="30272645.s0.e1" ontology_id="GO_0030299" text="intestinal cholesterol absorption" type="GO"/>
    <pair e1="30272645.s0.e0" e2="30272645.s0.e1" id="30272645.s0.p0" relation="true"/>
  </sentence>
  <sentence id="30272645.s1" text="Statins are the first line of lipid-lowering drugs for treating FH and other types of hypercholesterolemia, but new approaches are emerging, in particular negative regulation of receptor recycling antibodies, which are now being tested in clinical trials.">
    <entity charOffset="86-106" id="30272645.s1.e0" ontology_id="HP_0003124" text="hypercholesterolemia" type="HP"/>
    <entity charOffset="155-196" id="30272645.s1.e1" ontology_id="GO_0001920" text="negative regulation of receptor recycling" type="GO"/>
    <pair e1="30272645.s1.e0" e2="30272645.s1.e1" id="30272645.s1.p0" relation="true"/>
  </sentence>
</document>
